Market Research Blog – Page 395 – New Product Development

Global Magnetic Resonance Imaging Coils Market Poised for Unprecedented Growth, Reaching USD 20.3 Billion by 2033

The global magnetic resonance imaging coils market is poised for remarkable expansion, according to the latest report from Future Market Insights. The market, which generated substantial revenues of USD 9.2 billion in 2023, is projected to grow at a robust Compound Annual Growth Rate (CAGR) of 8.3% from 2023 to 2033, reaching an impressive USD 20.3 billion by the end of the forecast period.

This significant growth is primarily driven by the increasing global ageing population, which has heightened the demand for MRI procedures. As older adults become more prone to various health conditions that require advanced imaging for accurate diagnosis and treatment planning, the need for MRI technology continues to rise, fueling market expansion.

In addition to demographic shifts, recent innovations in MRI technology are contributing to the market’s upward trajectory. The development of both low-field and high-field strength MRI equipment has significantly enhanced the efficiency, accuracy, and accessibility of MRI procedures. These advancements are enabling more precise diagnostics and improving the overall effectiveness of imaging technologies.

A growing health consciousness, particularly in industrialized nations, is also playing a key role in the market’s growth. As populations become more aware of the benefits of early diagnosis and preventive healthcare, the demand for advanced diagnostic tools like MRI is intensifying. This heightened awareness further propels the MRI coils market forward, presenting significant opportunities for stakeholders across the healthcare and technology sectors.

The Future Market Insights report emphasizes the dynamic evolution of the MRI market, highlighting the pivotal role that continuous technological advancements and rising demand for sophisticated diagnostic procedures will play in shaping the MRI coils market over the next decade. As the healthcare landscape continues to evolve, MRI coils are set to be at the forefront of diagnostic innovation, offering immense growth potential for companies and investors alike.

Key Takeaways Magnetic Resonance Imaging Coils Market:

The MRI coils market has been experiencing significant growth over the years due to the increasing demand for MRI procedures across various medical specialties. The market is driven by factors such as technological advancements, rising prevalence of chronic diseases, and the need for accurate diagnostic imaging.
There are several types of MRI coils used for different applications, including head coils, spine coils, body coils, breast coils, cardiac coils, and extremity coils. Each coil type is designed to optimize image quality and provide better visualization of specific anatomical areas.
Technological advancements have played a crucial role in the development of MRI coils. Manufacturers are focusing on innovations such as multi-channel coils, phased-array coils, and flexible coil designs to enhance image quality, reduce scan time, and improve patient comfort.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Competitive Landscape:

The key players operating in the market are ESAOTE SPA, Bruker, Canon Medical Systems Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips N.V., MR Instruments, Inc., RAPID MR International, LLC, ScanMed, and Siemens Healthcare Private Limited.

Some of the recent developments of key Magnetic Resonance Imaging Coils providers are as follows:

In June 2020, the Neuroscience Foundation announced a project to develop 7T MRI technology for better neurovascular imaging in neurological illnesses. The Neuroscience Foundation provided funding for this study, which total USD 16,722.
In April 2018, ScanMed partnered with Fujikura, a Japanese company, to produce MRI coils.

Market Segments Covered in Magnetic Resonance Imaging Coils Market Analysis:

By Types:

Radiofrequency Coil
Gradient Coil

By Application:

Neurology
Cardiovascular
Spine and Musculoskeletal
Pediatric
Breast
Abdominal
Other Applications

By End Use:

Hospitals
Diagnostic Imaging Centers
Ambulatory Care Centers
Other End-uses

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Healthcare Cloud Infrastructure Market Projected to Reach USD 464.1 Billion by 2033

The global healthcare cloud infrastructure market has shown robust growth, with 2023 sales reaching an impressive USD 55.1 billion. According to the newly-released market analysis report by Future Market Insights, the market is expected to continue its rapid expansion, with a compound annual growth rate (CAGR) of 23.9%. By 2033, the Healthcare Cloud Infrastructure market is projected to soar to a staggering USD 464.1 billion.

This significant growth trajectory underscores the increasing adoption of cloud-based technologies within the healthcare sector. Healthcare organizations worldwide are embracing cloud solutions to enhance operational efficiency, improve patient care, and meet the growing demand for secure, scalable, and cost-effective infrastructure.

The report highlights the accelerating digital transformation of healthcare systems as a key factor fueling the demand for cloud infrastructure. This includes the migration of electronic health records (EHR), telemedicine platforms, and clinical data storage to cloud environments, which offer greater flexibility, security, and accessibility.

Future Market Insights further attributes the market’s strong growth to advancements in artificial intelligence, big data analytics, and machine learning, all of which benefit from the scalability and computational power that cloud infrastructure provides.

As the Healthcare Cloud Infrastructure market continues to evolve, stakeholders including healthcare providers, technology vendors, and regulatory bodies will need to collaborate to ensure data privacy, compliance, and security in this rapidly changing landscape.

Key Takeaways:

The global Healthcare Cloud Infrastructure market is experiencing significant growth, with 2023 sales reaching USD 55.1 billion. The market is poised to expand at a robust compound annual growth rate (CAGR) of 23.9%, reaching a projected valuation of USD 464.1 billion by 2033.
USA Market Analysis: North America’s healthcare cloud infrastructure market is expected to reach USD 135 billion by 2033, driven by the adoption of advanced cloud-based solutions and the presence of major IT players like IBM, Oracle, Microsoft, Amazon, and Salesforce. Strategic collaborations, such as the partnership between Microsoft and Allscripts in 2020, are fostering innovation in the sector.
United Kingdom Market Analysis: The UK market is projected to grow at a CAGR of 28.6%, reaching USD 32.9 billion by 2033, with an estimated absolute dollar opportunity of USD 30.2 billion during the forecast period.
Japan Market Analysis: Japan’s healthcare cloud infrastructure market is expected to reach USD 17.5 billion by 2033, growing at a CAGR of 23% and generating an absolute dollar opportunity of USD 15.3 billion.
South Korea Market Analysis: South Korea’s market is set to reach USD 7.1 billion by 2033, with a CAGR of 18% and an absolute dollar opportunity of USD 5.8 billion.

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Competitive Landscape:

The key players operating in the global healthcare cloud infrastructure market are Dell, Hewlett-Packard Enterprise Development LP, Microsoft, Oracle Corporation, and IBM.

A few of the recent developments in the Healthcare Cloud Infrastructure Market are:

In February 2022, IBM and SAP strengthened their partnership to enable clients to move their workloads from SAP solutions to the Cloud.
In February 2022, Kyndryl partnered with AWS to accelerate cloud adoption and innovation for customers.
In July 2021, Amazon announced the rollout of AWS for Health cloud services for healthcare, genomics, and biopharma.
In July 2021, Wellforce announced the migration of its Epic infrastructure to AWS cloud.

Market Segments Covered in Healthcare Cloud Infrastructure Market Analysis

By Component:

Hardware
- Server
- Storage
- Network
Services
- Software-as-a-service (SaaS)
- Infrastructure-as-a-service (IaaS)
- Platform-as-a-Service (PaaS)

By End-Use:

Healthcare Payers
Healthcare Providers

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa(MEA)

About Future Market Insights (FMI)

Contact Us:

Global Carrier Screening Market Set to Grow at a Robust CAGR of 12.4%, Projected to Reach USD 4,323.84 Million by 2033

The global carrier screening market is expected to experience significant growth, with a projected compound annual growth rate (CAGR) of 12.4% from 2023 to 2033. Estimated at USD 1,343.40 million in 2023, the market is anticipated to reach USD 4,323.84 million by 2033, driven by increasing demand for genetic testing, advancements in diagnostic technologies, and expanding funding from both public and private sectors.

Rising Demand for Genetic Testing Fuels Market Expansion:

The growing prevalence of genetic defects and chronic diseases has heightened the demand for carrier screening, making genetic testing a crucial tool for early diagnosis and prevention. Increased investments in healthcare and diagnostics are further propelling market growth, particularly with the introduction of innovative tests designed to enhance diagnosis and treatment.

As technology becomes more accessible, the adoption of carrier screening tests is expected to accelerate, providing better outcomes for individuals and families at risk for inherited genetic disorders.

Strategic Mergers, Acquisitions, and Innovations Drive Market Dynamics:

Industry players are strengthening their positions through strategic mergers, agreements, and acquisitions. In a notable move, Counsyl, Inc. expanded its partnership with Angsana Molecular & Diagnostics Laboratory in 2017 to sell the Extended Carrier Screening (ECS) test in Hong Kong. Subsequently, Myriad Genetics, Inc. acquired Counsyl in 2018, enhancing its portfolio of genetic tests.

Furthermore, the launch and approval of new carrier screening tests are expected to play a key role in fueling market expansion in the coming years.

Regional Insights: North America Leads, Europe Follows Suit

North America is set to maintain its dominance in the carrier screening market, driven by the approval of new products and the introduction of innovative genetic tests. A prime example is Sema4’s announcement in October 2019 of the availability of the Expanded Carrier Screen, a test that helps estimate the likelihood of a child inheriting a genetic condition.

Europe is also seeing strong growth, with the launch of cutting-edge screening tests such as QIAGEN’s QIAseq Expanded Carrier Screening Panel in June 2019. This test, which offers insight into genes associated with 200 disease indications, marks a significant milestone in molecular diagnostics.

The continued development of novel tests and increased adoption of carrier screening technologies are expected to sustain the market’s upward trajectory, benefiting both healthcare providers and patients worldwide.

Key Takeaways:

With a 12.9% CAGR between 2023 and 2033, the expanded carrier screening (ECS) segment is anticipated to be the key revenue-generating market.
Through 2033, the DNA sequencing market sector held a 39.9% revenue share, dominating the carrier screening market.
With a 47.1% carrier screening market share throughout the projection period, the laboratory segment dominated the global market.
With a share of 40.19% through 2033, the North American market is anticipated to hold a leading position in the carrier screening market.

Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!

Competitive Landscape:

There are several significant participants in the fragmented and competitive carrier screening market. A small number of significant businesses control a large portion of the market.

The market’s overall competitive rivalry is growing as a result of the existence of significant players including Abbott, F. Hoffmann-La Roche AG, Danaher Corporation (Cepheid), Illumina Inc., and Thermo Fisher Scientific Inc.

Recent Development:

Collaboration – To Co-develop:

Illumina and Kartos Therapeutics, Inc. announced a collaboration to co-develop a TP53 companion diagnostic (CDx) in April 2021. This CDx is based on the information provided by Illumina’s comprehensive genomic profile assay, TruSight Oncology.

Partnership – Utilizing the Skills of Both Parties:

Fulgent and Precision Genomics Laboratory (PGL) partnered in January 2019 to offer Columbia patients on-site performed, expanded carrier screening.

Acquisition – For Expansion:

Fulgent purchased CSI Laboratories (CSI) in August 2021 to increase its exposure to somatic molecular diagnostics and cancer testing. CSI provides molecular genetics, immunohistochemistry, fluorescence in-situ hybridization (FISH), and cytogenetic studies.

Key Players:

Myriad Genetics, Inc
Cepheid
Illumina
Thermo Fisher Scientific Inc.
F.Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
Otogenetics
MedGenome
GeneTech
Centogene N.V.

Key Segments:

By Type:

Expanded Carrier Screening
Targeted Disease Carrier Screening

By Medical Condition:

Cystic Fibrosis
Tay-Sachs
Gaucher Disease
Sickle Cell Disease
Spinal Muscular Atrophy
Other

By Technology:

DNA Sequencing
Polymerase Chain Reaction
Microarrays
Other

By End User:

Hospitals
Laboratories
Physician Offices & Clinics
Other

By Region:

North America
Europe
Asia Pacific
Latin America
The Middle East & Africa

About Future Market Insights (FMI)

Contact Us:

Global Healthcare Video Conferencing Solutions Market Set to Grow Significantly, Reaching USD 156.7 Million by 2033

The global healthcare video conferencing solutions market is poised for significant expansion, with projections indicating an increase from USD 91.7 million in 2023 to an anticipated USD 156.7 million by 2033. This remarkable growth, at a Compound Annual Growth Rate (CAGR) of 5.5%, underscores the growing importance of video conferencing technology in the healthcare sector.

The surge in demand for healthcare video conferencing solutions is largely driven by rapid technological advancements, including the integration of 5G networks and the widespread adoption of telemedicine platforms. Additionally, the COVID-19 pandemic has acted as a catalyst, accelerating the deployment of video conferencing technologies as healthcare providers increasingly seek innovative solutions to meet the evolving needs of patients and healthcare professionals.

According to a recent report by Future Market Insights, “The healthcare industry demands seamless video conferencing solutions that offer low power consumption, minimal latency, high-speed connectivity, and ample bandwidth. This is especially critical for data-intensive applications such as video conferencing, virtual reality, and augmented reality, which have become integral components of modern healthcare practices.”

North America remains a key contributor to the market’s growth, with the region experiencing significant demand for video conferencing technologies within healthcare. The surge in demand for continuous, high-quality virtual doctor-patient consultations and the presence of key corporations driving innovation have further fueled growth in this region.

With the healthcare landscape rapidly evolving and the increasing demand for telemedicine solutions, the market for healthcare video conferencing is expected to continue its upward trajectory in the coming years. Healthcare providers and technology innovators will be at the forefront of driving these advancements, ensuring seamless, high-quality virtual care for patients worldwide.

Driving Factors:

Technological Advancements: The integration of 5G technology is enhancing the quality and reliability of video conferencing, making it more accessible and efficient for healthcare providers.
Telemedicine Adoption: Increased reliance on telemedicine solutions during the COVID-19 pandemic has highlighted the critical role of video conferencing in ensuring continuous and effective patient care.

Key Takeaways:

The COVID-19 pandemic has accelerated the adoption of telemedicine and healthcare video conferencing solutions.
The market is segmented into deployment types (on-premise and cloud-based), components (hardware, software, and services), and applications (telemedicine, remote patient monitoring, and others).
The cloud-based deployment type is expected to witness the highest growth during the forecast period.
North America is the largest market for healthcare video conferencing solutions, followed by Europe and Asia-Pacific.

Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!

Competitive Landscape:

Key players in the Healthcare Video Conferencing Solutions Market include Adobe, Pexip AS, Zoom Video Communications, Inc., Intrado Corporation, Vidyo, Inc., Plantronics, Inc., Logitech, Huawei Technologies Co., Ltd., Cisco, and Avaya Inc.

A few recent developments in the Healthcare Video Conferencing Solutions market are:

In June 2021, Zoom Video Communications, Inc. announced that it had reached a deal to buy Karlsruhe Information Technology Systems – Kites GmbH, a firm specializing in real-time machine translation solutions.
In April 2021, Intrado Corporation introduced the SD-WAN Thin Edge, which was created in partnership with Infiot, a company that specializes in remote-first applications. It is intended for use with LTE cellular networks to connect distant workers, fixed and mobile locations, and IoT devices.
In February 2020, Logitech revealed that their new future Zone Wired headset would expand its video conferencing options for the entire workplace while also enhancing the personal workstation. With the addition of this new headset, Logitech offers a comprehensive modern portfolio of both wired and wireless headsets, allowing customers to select the best option for their needs.

In December 2020, Intrado Corporation, a provider of patient engagement solutions for hospitals, medical offices, and health systems, acquired Asparia, Inc.

Market Segments Covered in Healthcare Video Conferencing Solutions Market Analysis:

By Deployment Mode:

On-premise
Cloud-based

By Component:

Software
Hardware
Services

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

About Future Market Insights (FMI)

Contact Us:

Global Specialty Medical Chairs Market to Surge to USD 7.5 Billion by 2033, Driven by Growing Geriatric Population | FMI

The global specialty medical chairs market is witnessing remarkable growth, with the market value estimated at approximately USD 3.3 billion in 2023. Fueled by increasing healthcare needs among the aging population, the market is projected to expand at a robust CAGR of 8.7% between 2023 and 2033, ultimately reaching a valuation of USD 7.5 billion by the end of the forecast period.

This significant growth trajectory highlights an absolute dollar opportunity of nearly USD 4.2 billion during the forecast period. The increasing prevalence of chronic diseases and mobility challenges among the elderly, coupled with advancements in medical chair designs, is expected to bolster the adoption of specialty medical chairs across healthcare facilities globally.

Key Growth Drivers:

Aging Population: The rapid increase in the geriatric population is a primary driver of market growth. With aging comes a heightened demand for specialized healthcare solutions, including medical chairs tailored for comfort, ease of use, and specific medical procedures.
Technological Advancements: Innovations in ergonomic designs, enhanced mobility features, and multi-functionality are making specialty medical chairs indispensable in modern healthcare settings.
Healthcare Infrastructure Expansion: The growing investments in healthcare infrastructure across emerging economies are further supporting market expansion.

Market Outlook:

As the demand for high-quality patient care solutions grows, manufacturers are focusing on delivering customizable and technologically advanced medical chairs to meet the evolving needs of healthcare providers and patients. This is particularly critical as healthcare facilities prioritize patient comfort and operational efficiency.

Future Opportunities:

The specialty medical chairs market is set to benefit from the increasing focus on outpatient procedures and home healthcare services, creating opportunities for portable and versatile chair designs. Additionally, a surge in healthcare spending globally is expected to further propel market growth.

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!

Key Takeaways: Global Specialty Medical Chairs Market

Market Growth and Valuation:
- The global specialty medical chairs market is experiencing substantial growth, with a market value of USD 3.3 billion in 2023.
- Projected to grow at a CAGR of 8.7% from 2023 to 2033, the market is expected to reach USD 7.5 billion by the end of the forecast period.
United States Market Insights:
- In 2022, the U.S. market was valued at USD 1.2 billion, growing at a CAGR of 7.9% from 2018 to 2022.
- The U.S. market is forecasted to account for an absolute dollar opportunity of USD 1.6 billion between 2023 and 2033, driven by rising demand in dental, ophthalmology, and ENT clinics.
United Kingdom Market Highlights:
- The U.K. market is projected to reach USD 398 million by 2033, growing at a CAGR of 8.9%.
- The country is expected to generate an absolute dollar opportunity of approximately USD 227 million during the forecast period.
Japan Market Dynamics:
- Japan’s market is expected to grow at an impressive CAGR of 10.8%, reaching USD 275.9 million by 2033.
- The market will contribute an absolute dollar opportunity of USD 176.6 million over the forecast period.
South Korea Market Outlook:
- South Korea’s specialty medical chairs market is anticipated to reach USD 170.2 million by 2033, expanding at a CAGR of 10.4%.
- The market is expected to present an absolute dollar opportunity of USD 106.7 million during the forecast period.

The steady rise in healthcare infrastructure, coupled with an aging global population, continues to be a pivotal factor driving the specialty medical chairs market forward.

Competitive Analysis:

The Specialty Medical Chairs Market is primarily driven by key players such as A-dec, Inc., ActiveAid, Inc., DentalEZ, Inc., Fresenius Medical Care AG & Co. KGaA, Topcon Corp., Midmark Corp., Danaher, Dentsply Sirona, Planmeca Oy, and Hill Laboratories Company.

Noteworthy developments include A-dec, Inc.’s announcement in May 2021 of a strategic collaboration with KaVo, a leading dental products manufacturer, to enhance product quality and services for dental professionals worldwide.
Additionally, in June 2018, Dentsply Sirona expanded its Canadian presence through a distribution agreement with Henry Schein Canada, Inc., broadening its market reach.

Market Segments Covered in Specialty Medical Chairs Market Analysis:

By Type:

Examination
- Birthing
- Cardiac
- Blood Drawing
- Dialysis
- Mammography

Treatment
- Ophthalmic
- ENT
- Dental
- Other Treatments
- Other Rehabilitations

Rehabilitation
- Pediatric
- Bariatric
- Geriatric
- Other Rehabilitations

By Region:

North America

Europe
Asia Pacific
Latin America
Middle East & Africa

About Future Market Insights (FMI)

Contact Us:

Global Burns Treatment Market Set to Surge, Projected to Reach USD 2.59 Billion by 2033 with an Expected CAGR of 8%

The global burns treatment market is on an impressive growth trajectory, poised to achieve a valuation of USD 1.2 billion in 2023 and projected to reach a remarkable USD 2.59 billion by 2033, driven by a robust CAGR of 8% during the forecast period (2023-2033). This surge in market expansion underscores the increasing demand for advanced and effective solutions to manage burn injuries.

Market Highlights:

The burns treatment market forms a critical segment of the healthcare industry, addressing both minor and severe burn injuries that significantly impact patients’ quality of life. Over the historical period (2018-2022), the market registered a steady CAGR of 5%, reflecting consistent advancements in burn care products and treatment methodologies.

Key components fueling the market’s growth include:

Advanced Wound Care Solutions: Development of innovative wound dressings that promote healing and minimize infection risks.
Topical Agents and Pain Management: Increasing adoption of specialized topical treatments and pain management products for effective recovery.
Reconstructive Surgery Products: Rising demand for reconstructive procedures to restore functionality and aesthetics for burn victims.

Driving Forces Behind Market Growth:

Rising Incidence of Burn Injuries: Increased prevalence of burn injuries globally, particularly in developing regions with limited safety infrastructure.
Technological Advancements: Breakthroughs in burn care technology, such as bioengineered skin substitutes and advanced topical agents, enhance treatment outcomes.
Supportive Healthcare Policies: Governments and healthcare organizations are investing heavily in improving burn care facilities and accessibility.

Opportunities Ahead:

The market offers immense potential for innovation, particularly in:

Telemedicine Integration: Remote consultation and monitoring to ensure timely burn care in underserved areas.
Customized Treatment Solutions: Growing focus on patient-specific solutions to optimize recovery.

Future Outlook:

As the global healthcare landscape evolves, the burns treatment market is set to benefit from increased awareness, improved infrastructure, and expanding product pipelines. Key players in the industry are expected to focus on R&D investments, strategic partnerships, and product launches to capitalize on the burgeoning demand.

The Burns Treatment Market stands at the cusp of transformative growth, offering a promising horizon for patients and stakeholders alike.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Key Takeaways from the Market Study:

From 2018 to 2022, the burn treatment market grew at a CAGR of 5%.
The global burn treatment market is expected to grow with a 8% CAGR during 2023 to 2033.
As of 2033, the burn treatment Market is expected to reach US$ 2.59 Billion
According to the FMI analysis, hospitals account for the largest market share.
North America is expected to possess 25% market share for the burn treatment market.
The Asia Pacific market is predicted to increase significantly throughout the forecast period, with a CAGR of 5% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering burn treatment.” says an FMI analyst

Market Competition:

Key players in the Burns Treatment Market are Smith & Nephew, ConvaTec Group, B. Braun Melsungen AG, Molnlycke Health Care, Integra LifeSciences, Coloplast A/S, Paul Hartmann AG, 3M, Acelity L.P. Inc., and Medtronic among other global players.

In June 2022, the British Columbia Children’s Hospital, Canada, received about USD 1 million from the BC Professional Fire Fighters Burn Fund to support specialized care for kids with burn injuries.
In June 2021, the United States Food and Drug Administration (FDA) approved Avita Medical’s expanded use of the RECELL System in combination with meshed autografting for treating all sizes of acute full-thickness thermal burn wounds for both pediatric and adult patients.

Key Segments Profiled in the Burns Treatment Industry Survey:

Treatment Type:

Wound Care Dressings
- Antimicrobial Dressings
- Hydrocolloid Dressings
- Hydrogel Dressings
- Film Dressings
- Foam Dressings
- Alginate Dressings
Wound Care Therapy
- Thermal Burn Therapy
- Negative Pressure Wound Therapy
- Ultrasound Therapy
- Hyperbaric Oxygen Therapy
Medications
- Burn Creams & Ointments
- Anti-infective Drugs
- Painkillers & Anti-anxiety Medications
- IV-Fluids & Therapeutic Peptide

Degree of Burn

First-degree Burns
Second-degree Burns
Third-degree Burns

Region:

North America
Latin America
Europe
South Asia
East Asia
Middle East & Africa
Oceania

About Future Market Insights (FMI)

Contact Us:

Global Cerebral Aneurysm Management Market to Reach USD 2.98 Billion by 2033, Growing at a 6.7% CAGR

The global cerebral aneurysm management market is poised for significant growth, with projections estimating a market value of USD 1.56 billion in 2023 and an impressive USD 2.98 billion by 2033. This growth trajectory, marked by a robust CAGR of 6.7% during the forecast period of 2023 to 2033, underscores the increasing demand for advanced treatment options in managing cerebral aneurysms.

Key Growth Drivers:

The expansion of the cerebral aneurysm management market is primarily driven by:

Rising Geriatric Population: The global rise in the aging population has led to an increased prevalence of cerebral aneurysms, necessitating enhanced diagnostic and therapeutic solutions.
Advancements in Medications and Treatments: The availability of innovative and effective medications, alongside advanced surgical techniques, has significantly contributed to the market’s growth.

In the historical period from 2018 to 2022, the market exhibited steady growth, registering a CAGR of 4%, reflecting the foundational developments in treatment methodologies and increased awareness of cerebral aneurysm management.

Understanding Cerebral Aneurysm Management:

Cerebral aneurysm management involves the diagnosis and treatment of weak spots in brain blood vessels that can bulge or rupture, potentially causing life-threatening subarachnoid hemorrhages. Management typically encompasses both medical and surgical approaches aimed at:

Reducing the risk of aneurysm rupture.
Preventing further bleeding in cases of ruptured aneurysms.
Minimizing neurological damage through timely intervention.

Future Outlook:

As healthcare systems worldwide continue to focus on improving outcomes for patients with cerebral aneurysms, the demand for cutting-edge diagnostic tools and minimally invasive surgical techniques is expected to rise. Market players are also investing in research and development to introduce innovative products and therapies that address the growing patient needs.

The promising growth of the cerebral aneurysm management market highlights the critical role of technological advancements and demographic shifts in shaping the future of neurological care.

Key Takeaways from the Market Study:

The Cerebral aneurysm management market is expected to grow at a value of 6.7% CAGR in the forecast period 2023-2033.
By distribution channel, hospital pharmacies are expected to hold 40% of the market share in 2023 for Cerebral aneurysm management market.
North America is expected to possess 45% market share for Cerebral aneurysm management market in 2023.
Asia Pacific Cerebral aneurysm management market size is expected to possess 37% market share in 2023.

“Increase in technologically advanced healthcare infrastructures along with awareness of treating Cerebral aneurysm is driving the growth of the Cerebral aneurysm management market.” states an FMI analyst

Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!

Competitive Landscape:

Key players in the cerebral aneurysm management market are Biogen, Pfizer Inc, Hoffmann-La Roche Ltd, Merck Sharp & Dohme Corp, Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Orion Corporation, UCB S.A., Acadia Pharmaceuticals Inc, Lundbeck A/S, Mitsubishi Tanabe Pharma Corporation

Sanofi, a key player in the cerebral aneurysm management market is focusing on integrating technology to offer diagnostic test for treating cerebral aneurysm.
Biogen, another key player in the cerebral aneurysm management market is focusing on investing in research and development for innovating medications.

Key Segments Profiled in the Cerebral Aneurysm Management Market Survey:

Drug Class:

Antihypertensives
Antiepileptics
Analgesics
Antiemetics
Antacids

Route of Administration:

Oral
Injectable
Transdermal

Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
MEA

About Future Market Insights (FMI)

Contact Us:

Global Antibody-Mediated Rejection Prevention Market Set to Witness Robust Growth, Projected to Reach USD 528.31 Million by 2033

The global antibody-mediated rejection prevention market is poised for remarkable expansion, reflecting the increasing demand for innovative solutions in organ transplant care. In 2023, the market is valued at USD 89 million, and it is projected to grow at a compelling compound annual growth rate (CAGR) of 16% through 2033. By the end of this period, the market valuation is expected to soar to USD 528.31 million.

The significant growth trajectory underscores the heightened focus on mitigating antibody-mediated rejection, a critical complication in organ transplantation that often compromises the success of the procedure. With advancements in immunology and biotechnology, novel therapeutics and preventive measures are being developed, driving the market forward.

Key Market Drivers:

Rising Transplantation Rates: The increasing prevalence of chronic diseases leading to organ failure has escalated the number of organ transplants globally.
Technological Innovations: Continued advancements in monoclonal antibodies and immune-modulating therapies are enhancing treatment efficacy.
Growing Awareness: Greater awareness among healthcare providers and patients about AMR risks and solutions is boosting demand for preventive strategies.

Market Outlook:

The antibody-mediated rejection prevention market presents a lucrative opportunity for stakeholders, including pharmaceutical companies, research institutions, and healthcare providers. With a robust pipeline of innovative products and an expanding patient base, the market is anticipated to witness sustained growth over the forecast period.

Industry players are encouraged to leverage this momentum by accelerating research and development efforts, forging strategic collaborations, and ensuring equitable access to emerging therapies.

Key Takeaways from the Market Study:

The immunomodulators market is expected to grow at a CAGR of 6.3% over the forecast period.
From 2018 to 2022, sales increased significantly at a CAGR of 14%.
The global monoclonal antibodies segment was worth USD 186 million in 2021
The global monoclonal antibodies segment is expected to grow at a CAGR of 11% between 2023 and 2033.
The global market for antibody-mediated rejection prevention is expected to be worth USD 528.31 million.

“The population of people with end-stage kidney disease is getting older. Nearly half of all new patient populations are over 65, with one-third being over 70. As a result, late kidney transplant failure is common among the elderly, which is expected to drive the antibody-mediated rejection prevention market,” says the FMI analyst.

Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!

Key Market Players:

Key players in the Antibody-mediated Rejection Prevention market are CSL Behring, Hansa Biopharma, Sanofi, Talaris Therapeutics, Horizon Therapeutics, Novartis AG, Biogen, Teva Pharmaceutical Industries Ltd., Eli Lilly, and Company, Bristol-Myers & Squibb Company.

Some of the latest developments are below:

Horizon Therapeutics plc disclosed in February 2021 that it will purchase Viela Bio, Inc. to substantially expand its product portfolio and flourish its rare disease medical portfolio.
The trial’s Independent Data Monitoring Committee has recommended that the evaluation of Jardiance® (empagliflozin) in grownups with chronic kidney disease (CKD) be halted early. Following an official interim analysis that fulfilled predeﬁned criteria for favorable efficacy, the Medical Research Council (MRC) Population Health Research Unit reported in March 2022.

Key Segments Profiled in the Antibody-mediated Rejection Prevention Market Survey

By Treatment:

Monoclonal Antibodies
Cysteine Protease Inhibitors
Immunomodulators
Plasmapheresis

By End User:

Hospitals
Specialty Clinics

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Global Advanced Cancer Pain Management Market Set to Surge with Significant Growth USD 11,540 Million by 2033, growing at a 4.74% CAGR: FMI Report

The global advanced cancer pain management market is poised for remarkable expansion, with its valuation anticipated to reach an impressive USD 7,265.44 million in 2023 and projected to climb to USD 11,540 million by 2033, marking a steady CAGR of 4.74% during the forecast period.

This substantial growth is attributed to rapid technological advancements in neuromodulation techniques for treating neuropathic cancer pain, heightened investments in cancer research, and the burgeoning global burden of cancer pain. Extensive research and development activities aimed at innovating novel therapies for effective pain management are further driving market expansion.

Emerging trends in patient-controlled analgesia and enhanced research into the mechanisms of advanced cancer pain are contributing significantly to market growth. With increasing cancer cases, the demand for advanced cancer pain management solutions continues to rise, especially for addressing pain caused by nerve compression and tumor progression.

Additionally, the prevalence of genetic diseases, such as Acute Lymphoblastic Leukemia, is fueling the demand for specialized pain management therapies. Governments and healthcare organizations worldwide are taking proactive measures, including favorable funding and initiatives, to address the alarming rise in cancer prevalence. This has encouraged healthcare companies to prioritize cancer pain management as a critical component of treatment.

As technological advancements continue to unlock better alternatives for pain management, the global advanced cancer pain management market is well-positioned for sustained growth. This trajectory underscores the urgent need for effective, sensitive, and efficient pain management methods to enhance the quality of life for cancer patients worldwide.

Key Takeaways:

North America is expected to dominate the industry while reaching market share of around 42.9% by end of the forecast period.
The market in Asia Pacific is projected to witness fastest CAGR of 5.5% during the projected period.
By drug class, ‘Cannabinoids’ is projected to account for 35% market share by end of the forecast period.
Hospital pharmacies are expected to dominate the market by distribution channel, with a market share of 67.2 % by 2033.

Mounting research activities in finding alternative options to manage advanced cancer pain will fuel the market growth- Comments an FMI Analyst

High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report!

Competitive Landscape:

The Advanced cancer pain management market is extremely competitive and consists of several industry players. These players are developing novel delivery systems for treating Advanced cancer pain management. This is estimated to propel Advanced cancer pain management market. The key players in this industry are: WEX Pharmaceuticals Inc, Jazz Pharmaceuticals, Nobelpharma Co., Ltd, Tetra Bio-Pharma Inc., Pfizer, Recipharm, eurofins, Sigma-Aldrich, AstraZeneca, GlaxoSmithKline plc. Key market players are tending towards adoption of inorganic growth strategies like acquisition, mergers, partnerships, and collaboration in order to bolster their product portfolio. This is anticipated to fuel the global Advanced cancer pain management market.

In October 2022: Parker Laboratories Inc., which develops, manufactures, and sells pain relief creams, ultrasound and electromedical contact media, and institutional cleaners and disinfectants, is increasing its analgesics line. The company has added Helix CBD Therapy Cream, CBD Clinical Cream, and Tri-Active Therapy Cream to its HelixTM line.
In September 2022, Compass Group Equity Partners which is a St. Louis-based private equity firm, declared a strategic partnership with Mays & Schnapp Neurospine and Pain (“Mays & Schnapp”), based in Memphis, interventional pain management practice serving patients in Tennessee and Mississippi
In July 2021: Venus Remedies Limited announced launch of a consumer healthcare division that will provide various products for pain management
In January 2021: Boston Scientific Corporation announced the launch of Wave Writer Alpha, a portfolio of spinal cord stimulator systems that combine therapy options for personalized pain relief.

Key Companies Profiled:

WEX Pharmaceuticals Inc.
Jazz Pharmaceuticals
Nobelpharma Co., Ltd
Tetra Bio-Pharma Inc.
Pfizer
Recipharm
eurofins
Sigma-Aldrich
AstraZeneca
GlaxoSmithKline plc

Key Segments Profiled in the Advanced Cancer Pain Management Industry Survey:

By Drug Class:

Monoclonal Antibody
Cannabinoid
Aminoindane

By Route of Administration:

Intravenous
Oral
Inhalational

By Distribution Channel:

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Global Pouch Packaging Machines Market Set to Reach USD 1.8 Billion by 2032, Driven by Automation and Technological Advancements

The global pouch packaging machines market is set to experience significant growth, with a projected valuation of USD 1.2 billion in 2022, expanding at a compound annual growth rate (CAGR) of 4.1% to reach USD 1.8 billion by 2032, according to recent research by Future Market Insights. The market’s upward trajectory is being driven by growing demand for packaging solutions in food, beverages, pharmaceuticals, and other end-user industries, combined with rapid advancements in automation and printing technologies.

As the global pouch packaging industry continues to expand, pouch packaging machines, which are essential for the packaging of liquids, powders, and solid products, have become increasingly popular across industries. These machines offer flexibility, efficiency, and cost-effectiveness in producing different types of pouches such as stand-up pouches, zipper pouches, and spouted pouches.

Get a Sample PDF of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4772

Key Drivers of Market Growth

The food and beverage industry segment primarily drives the pouch packaging machines market. With a steadily growing global population, the demand for packaged food is on the rise. Consumers are increasingly turning to retail marts and supermarkets, driving the demand for ready-to-eat packaged food products. Heightened concerns about food safety and hygiene further contribute to the preference for properly packaged food items.

Pouch packaging offers several advantages, including low cost, ease of handling, and space-saving characteristics. These benefits make pouch packaging a preferred choice for many brands, ultimately reducing overall production and transportation costs. The surge in demand for packaged food products is a major factor propelling the growth of the pouch packaging machines market.

Country-wise Insights

United States: According to a report published by The USA Department of Agriculture (USDA), the number of grocery stores and convenience stores in the USA has increased significantly between 2009 and 2014. This growth in retail infrastructure presents positive growth opportunities for the pouch packaging machine market in the country.

Automation Segment Insights: Automatic Pouch Packaging Machines

The automatic pouch packaging machines segment is expected to dominate the market, capturing approximately 65% of the market value share by the end of the forecast period. Industries favor automatic pouch packaging machines due to their ability to deliver maximum output in minimal time without requiring human intervention. These machines significantly reduce labor costs and offer unmatched accuracy and strength compared to manual packaging processes. Industries engaged in large-scale production with continuous operations opt for automatic pouch packaging machines to streamline their manufacturing processes effectively.

Future Growth Opportunities in Pouch Packaging Machines Industry:

Single-serve Packaging for Convenience Foods: With the increasing demand for on-the-go and convenience foods, there’s a growing opportunity for pouch packaging machines that specialize in single-serve packaging formats.
Pharmaceutical Packaging: The pharmaceutical industry is witnessing rapid growth, and there’s a rising need for pouch packaging machines that meet stringent requirements for packaging drugs, ensuring product safety and compliance with regulations.
E-commerce Packaging Solutions: The booming e-commerce sector requires efficient and adaptable packaging solutions. Pouch packaging machines tailored for e-commerce applications, such as customizable packaging and automated fulfillment processes, present significant growth opportunities.
Emerging Markets Expansion: Emerging markets, particularly in Asia-Pacific and Latin America, offer immense growth potential for pouch packaging machines due to increasing industrialization, urbanization, and changing consumer lifestyles.
Health and Beauty Products: The health and beauty industry is experiencing robust growth globally. Pouch packaging machines catering to this sector, offering features such as precision filling, attractive design options, and product protection, are poised for significant expansion.

Access Full Report: https://www.futuremarketinsights.com/reports/pouch-packaging-machines-market

Market by Category

By Automation Type,

Automatic
Semi-automatic
Manual

By Output,

Small Scale
Medium Scale
Large Scale

By End-use,

Food & Beverage
Beauty & Personal Care
Pharmaceutical
Automotive
Homecare
Pet care
Industrial

By Region,

North America
Latin America
Europe
South Asia
East Asia
Middle East & Africa (MEA)
Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube